| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb2fc1eb37a6ea4760546afb2b89e92f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-87 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
2018-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02a10abf1c284a83a0d4f6a333ac12d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9a5ddf5c1b871d64383acc85ac4c3b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_152be316246820834f9c562d076e850b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02bd33ea5aa446813ce979eb0d70f780 |
| publicationDate |
2019-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-3079025-A1 |
| titleOfInvention |
Enhanced transfection efficiency of human pluripotent stem cells through the effects of retinoic acid analogue (ttnpb), rho-associated kinase inhibitor (y-27632), and pparyagonist(pioglitazone) |
| abstract |
The present disclosure relates generally to enhance transfection efficiency of human pluripotent stem cells through the combinatorial effects of retinoic acid analogue (TTNPB) and Rho-associated kinase inhibitor (Y-27632), and PPAR? agonist (Pioglitazone). |
| priorityDate |
2017-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |